We are monitoring the impact of COVID-19 on Europe Contraceptives Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1156
Share on
Share on

Europe Contraceptives Market Research Report – Segmented By Drug Type, Medical Devices, End-Users, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1156
Pages: 136

Europe Contraceptives Market Size (2021 to 2026)

The size of the Europe Contraceptives Market is predicted to be worth USD 8.7 billion by 2026 from USD 6.35 billion in 2021, growing at a CAGR of 6.50% during the forecast period. The European contraceptives market enjoys high product penetration, especially in subdermal implants and intrauterine devices (IUD).

Male and female condoms, vaginal implants, subdermal implants, sponges, IUDs, and diaphragms are essential devices and accounted for the market's most significant share in terms of revenue. It is attributed to growing awareness about STD (Sexually transmitted disease) and the efficiency of condoms to inhibit infections, including HIV. In addition, in a recent study, subdermal implants have been recognized to have an immense potential to meet women's needs for family planning.

Factors such as increasing active female contraceptive devices and drugs, advancement in technologies, and increasing initiatives from the government and NGOs to promote contraceptives are primarily accelerating the growth rate of the European contraceptives market. The prevalence of sexually transmitted illnesses is on the rise, eventually leveling up the market's demand. Furthermore, the government is taking initiatives to promote knowledge about contraception and family planning which can drive growth in the market. As now a days huge number of women are prioritizing their professions. Therefore, there is in delaying childbearing with the use of contraceptive devices and medications.

Other drivers can be the increase in the demand for contraceptives, and Low-income women (those with incomes less than 200 percent of the federal poverty threshold), women aged from 18–24, have the highest incidence of unintended pregnancies with increasing rates.

However, the market's growth is expected to be hampered by the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility. In addition, due to the lack of awareness, particularly among young, poorer, and unmarried people, a limited number of choice methods, limited access to services. Fear of side-effects, poor quality of available services, and gender-based barriers to accessing services can affect the market growth.

Impact of COVID-19 on the European contraceptives market:

The contraceptive market in Europe is significantly impacted by COVID 19. The public contraceptive services were shut down due to COVID 19 restrictions, and therefore many women were not able to access these services. According to United Nations Population Fund (UNFPA), about 114 low and middle-income countries expect about 7 million pregnancies due to inaccessible contraception.  This, in turn, is believed to weaken the healthcare system more, and there could be a shortage of skilled workers such as doctors and nurses.

This research report on the European Contraceptives Market has been segmented & sub-segmented into the following categories:

By Drug Type: 

  • Contraceptive Pills
  • Topical Contraceptives
  • Contraceptive Injectable
  • Others (Contraceptive Gels, Jellies, and Creams)

By Medical Devices: 

  • Male Contraceptive Devices (Condoms)
  • Female Contraceptive Devices
    • Female Condoms
    • Intrauterine Devices
      • Hormonal IUD’s
      • Copper IUD’s
  • Contraceptive Sponges
  • Contraceptive Diaphragms
  • Subdermal Contraceptive Implants
  • Contraceptive Patches
  • Non-Surgical Permanent Contraceptive Devices

By End User: 

  • Hospitals
  • Home Care
  • Clinics
  • Ambulatory Surgical Centres

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the market for contraceptive devices in the United Kingdom is expected to grow at a CAGR of about 8.01% during the projected period. The primary drivers driving market expansion are the rising regional population knowledge of contraceptive techniques, investments by key companies in developing novel devices, and favorable government measures to enhance product availability.

The German Contraceptive Devices Market is expected to develop at a CAGR of 4.8% during the forecast period.

The contraceptive device market in Spain is anticipated to grow to USD 0.197 billion by the end of 2021, registering a CAGR of 7.86% during the forecast period.

The France contraceptive devices market is expected to grow at an 8.07% CAGR during the projected period. Rising knowledge of contraceptive techniques among the French population, investments by important companies in developing novel devices, and favorable government measures to enhance access to goods are the primary drivers driving growth.

The Italy Contraceptive Devices Market is estimated to grow at a CAGR of 3.9%. Increased awareness of sexually transmitted diseases (STDs) and the rising prevalence of unplanned pregnancies are two reasons propelling the industry forward.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the European contraceptives market profiled in this report are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug type                              

                                5.1.1 Contraceptive pills               

                                5.1.2 Topical contraceptives       

                                5.1.3 Contraceptive injectable   

                                5.1.4 Others (contraceptive gels, jellies and creams)        

                5.2 By Medical Devices                 

                                5.2.1 Male contraceptive devices             

                                5.2.2 Female contraceptive devices        

                                                5.2.2.1 Female condoms

                                                5.2.2.2 Intrauterine devices

                                               

                                               

                                                5.2.2.3 Contraceptive sponges

                                                5.2.2.4 Contraceptive diaphragms

                                                5.2.2.5 Contraceptive patches

                                                5.2.2.6 Subdermal contraceptive implants

                                                5.2.2.7 Non-surgical permanent contraceptive devices

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 U.K

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bayer HealthCare AG                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Teva Pharmaceutical Industries Limited                         

                8.3 Medisafe Distribution Inc                     

                8.4 Pace Pharmaceuticals Inc                     

                8.5 Medicines360                            

                8.6 Church & Dwight, Co., Inc.                   

                8.7 Actavis, Inc                 

                8.8 CooperSurgical                         

                8.9 Merck & Co., Inc                       

                8.10 Reckitt Benckiser plc                            

                8.11 Mayer Laboratories, Inc                      

                8.12 Pfizer, Inc                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Contraceptives Market, By Drug type, From 2021 to 2026 (USD Billion)
  2. Europe Contraceptive pills Market, By Region, From 2021 to 2026 (USD Billion)
  3. Europe Topical contraceptives Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Contraceptive injectable Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe Contraceptives Market, By Medical Devices, From 2021 to 2026 (USD Billion)
  6. Europe Male Contraceptive devices Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Female Contraceptive devices Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Contraceptives Market, By End users, From 2021 to 2026 (USD Billion)
  9. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Home care Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe Ambulatory Surgical Centres Market, By Region, From 2021 to 2026 (USD Billion)
  13. U.K. Contraceptives Market, By Drug type, From 2021 to 2026 (USD Billion)
  14. U.K. Contraceptives Market, By Medical Devices, From 2021 to 2026 (USD Billion)
  15. U.K. Contraceptives Market, By End users, From 2021 to 2026 (USD Billion)
  16. Germany Contraceptives Market, By Drug type, From 2021 to 2026 (USD Billion)
  17. Germany Contraceptives Market, By Medical Devices, From 2021 to 2026 (USD Billion)
  18. Germany Contraceptives Market, By End users, From 2021 to 2026 (USD Billion)
  19. France Contraceptives Market, By Drug type, From 2021 to 2026 (USD Billion)
  20. France Contraceptives Market, By Medical Devices, From 2021 to 2026 (USD Billion)
  21. France Contraceptives Market, By End users, From 2021 to 2026 (USD Billion)
  22. Italy Contraceptives Market, By Drug type, From 2021 to 2026 (USD Billion)
  23. Italy Contraceptives Market, By Medical Devices, From 2021 to 2026 (USD Billion)
  24. Italy Contraceptives Market, By End users, From 2021 to 2026 (USD Billion)
  25. Spain Contraceptives Market, By Drug type, From 2021 to 2026 (USD Billion)
  26. Spain Contraceptives Market, By Medical Devices, From 2021 to 2026 (USD Billion)
  27. Spain Contraceptives Market, By End users, From 2021 to 2026 (USD Billion)
  28. Europe Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  29. Europe female condoms Market, By Region, From 2021 to 2026 (USD Billion)
  30. Europe intrauterine devices Market, By Region, From 2021 to 2026 (USD Billion)
  31. Europe contraceptive sponges Market, By Region, From 2021 to 2026 (USD Billion)
  32. Europe contraceptive diaphragms Market, By Region, From 2021 to 2026 (USD Billion)
  33. Europe contraceptive patches Market, By Region, From 2021 to 2026 (USD Billion)
  34. Europe subdermal contraceptive implants Market, By Region, From 2021 to 2026 (USD Billion)
  35. Europe non-surgical permanent contraceptive devices Market, By Region, From 2021 to 2026 (USD Billion)
  36. U.K. Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  37. Germany Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  38. France Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  39. Italy Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  40. Spain Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  41. Europe Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  42. Europe female condoms Market, By Region, From 2021 to 2026 (USD Billion)
  43. Europe intrauterine devices Market, By Region, From 2021 to 2026 (USD Billion)
  44. Europe contraceptive sponges Market, By Region, From 2021 to 2026 (USD Billion)
  45. Europe contraceptive diaphragms Market, By Region, From 2021 to 2026 (USD Billion)
  46. Europe contraceptive patches Market, By Region, From 2021 to 2026 (USD Billion)
  47. Europe subdermal contraceptive implants Market, By Region, From 2021 to 2026 (USD Billion)
  48. Europe non-surgical permanent contraceptive devices Market, By Region, From 2021 to 2026 (USD Billion)
  49. U.K. Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  50. Germany Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  51. France Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  52. Italy Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  53. Spain Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Billion)
  54. Europe Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Billion)
  55. Europe Hormonal IUD's Market, By Region, From 2021 to 2026 (USD Billion)
  56. U.K. Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Billion)
  57. Germany Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Billion)
  58. France Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Billion)
  59. Italy Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Billion)
  60. Spain Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample